Dedicated to NPs, PAs and rheumatologists who diagnose and treat arthritis and other musculoskeletal conditions.
|
|
Dedicated to NPs, PAs and rheumatologists who diagnose and treat arthritis and other musculoskeletal conditions.
|
|
key topics
navigation |
Anti TNF MedicationsRA Study: Etanercept Shows Sustained Efficacy For Up To Nine Years In assessing 77 patients with early RA and 280 patients with longstanding RA who completed eight years of treatment with etanercept, researchers found that 75 percent of patients with early RA and 76 percent of those with longstanding RA achieved an ACR 20 score. A.L. Study Says: Abatacept Offers Sustained Benefits In RA Patients After two years of receiving treatment with abatacept, patients with RA maintained significant improvements, according to study findings that were presented ... Study Raises Questions On Anti-TNF Therapy Study Raises Questions On Anti-TNF Therapy News & Trends: Study Raises Questions On Anti-TNF Therapy - By Anthony Leone, Associate Editor A recently published retrospective review of randomized trials involving anti-tumor necrosis factor (TNF) agents suggests increased risks of serious infections and malignancies among patients who take these medications. The study also noted that malignancies were more common in patients who took higher doses of anti-TNF drugs as opposed to patients who ... What Does The Future Hold For Etoricoxib? Two studies published separately in The Lancet in recent months discussed results from the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study, which involved 34,701 patients with OA or RA. Combination Therapy For Early RA: What One Study Reveals By Aaron Becker, Associate Editor When it comes to early rheumatoid arthritis (RA), initial combination therapy provides ? While the study suggests that cognitive behavioral therapy can be effective for patients with depression... Key Insights On Diagnosing And Treating RA Our roundtable experts offer perspectives from their clinical experience in discussing exercise recommendations for patients with RA, considerations for when to switch from anti-TNF agents to biologic therapies, and how to differentiate between RA and fibromyalgia. Without further delay, here is what they had to say. Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis News & Trends: Studies Show Impact Of Anti-TNF Meds For Ankylosing Spondylitis - By Anthony Leone, Associate Editor Results of a five-year study showed that the majority of patients taking infliximab (Remicade, Centocor) for ankylosing spondylitis safely tolerated the drug and a third of the patients had complete remission without any major side effects. Two recent studies show promising findings in the use of anti-TNF drugs to ... Educating Patients On Self-Management Educating Patients On Self-Management Patient Education: Educating Patients On Self-Management - By Charlene M. Morris, MPAS, PA-C Historically, people who hurt would see their primary care practitioners. In addition, these disciplines provide positive mental benefits and impart socialization that many patients have difficulty pursuing as their disease progresses.3 The issue of heart and lipid health is tantamount as patients with rheumatoid disease have an increased cardiovascular risk on ...
|
July 19, 2008
A complimentary CME Webcast Event |
Emerging Concepts In Treating Rheumatoid Arthritis
A Guide To Viscosupplementation For Osteoarthritis Knee Pain
A Guide To Infusion Therapy For Patients With Rheumatoid Arthritis